CMS’ Proposed GLP-1 Rule Complicates Path Forward For Legislation

By Luke Zarzecki / December 13, 2024 at 12:38 PM

Advocates are debating which version of the Treat and Reduce Obesity Act (TROA) to continue to champion after the Biden administration proposed a new rule for CMS to cover weight-loss medications for obesity.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

CMS’ Proposed GLP-1 Rule Complicates Path Forward For Legislation

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.